The Marque The Marque
The Marque
About The Marque Profiles Press Contact

Jeffrey Leiden

Executive Chairman

Vertex Pharmaceuticals

Boston, MA, USA

Jeffrey Leiden
Ronel Lehmann
Finito Education
Dominic Lester
Jefferies

Jeffrey Leiden’s Biography

Jeffrey Leiden, M.D., Ph.D. is an award-winning physician-scientist, entrepreneur, advisor and academic, who serves as Executive Chairman at Vertex Pharmaceuticals.

He spent eight years as Chairman, President and CEO of Vertex and helped pioneer the first medicines in history to treat the underlying cause of cystic fibrosis. Dr. Leiden has been involved with Vertex for over a decade, having first served as a board member. His leadership has been defined by innovation and a commitment to developing transformative medicines. He is passionate about giving back to the community and making STEM education accessible to underrepresented students and has initiated many programs through Vertex and public-private partnerships to support this.

Prior to Vertex, Dr. Leiden was a Managing Director of Clarus Ventures, a venture capital firm focused on life sciences investments. He also served as President, COO and CSO at Abbott Laboratories, where he oversaw the company’s pharmaceutical business globally. Consistently committed to achieving life-changing strides in medicine, Dr. Leiden led the development of numerous medicines at Abbott.

Earlier in his career, Dr. Leiden was appointed as Professor of Medicine at Harvard Medical School and Elkin R. Blout Professor of Biological Sciences at the Harvard School of Public Health. In addition to his academic appointments, he worked as a physician, having been appointed as Chief of Cardiology at The University of Chicago Medical Center, where he was also the Rawson Professor of Medicine and Pathology and an Attending Physician. During this time, he co-founded several biotechnology companies including Vical and Cardiogene.

Dr. Leiden has held many board positions throughout his career and currently serves as Chairman at Casana, a health monitoring platform, as well as Tmunity Therapeutics, a biotherapeutics company.

Dr. Leiden has been presented with numerous awards, including the Forbes Lifetime Achievement Award.

Jeffrey Leiden’s Newsfeed

The Boston Globe
New Chairman Of Mass. Competitive Partnership Aims To Use Its Power To Reshape Local Economy

As the new chairman of Vertex, Jeffrey Leiden aims to help the local community by supplying employment for those who lost their jobs during the COVID-19 pandemic.

Forbes
A Tribute to Jeffrey Leiden: Forbes Lifetime Achievement in BioPharma Award | 2020 Forbes Healthcare

Jeffrey Leiden, M.D., Ph.D., Executive Chairman of Vertex Pharmaceuticals, is honored with a Lifetime Achievement in BioPharma Award during the Forbes Healthcare Summit.

View allHide

Jeffrey Leiden’s Background

Vertex Pharmaceuticals
Executive Chairman
2012 - Present
Boston, MA, USA
Jeffrey Leiden has served as the Chairman of Vertex since 2012. Vertex is a leading biotechnology company that invests in scientific innovation to create transformative medicines.
Vertex Pharmaceuticals
Chairman, President & CEO
Boston, MA, USA
Before his appointment as Executive Chairman at Vertex, Dr. Leiden led as Chairman, President and CEO.
View allHide

Jeffrey Leiden’s Gallery

Board Positions

Tmunity
Chairman
Jan 2021 - Present
Philadelphia, PA, USA
Tmunity Therapeutics Incorporated is a distinguished biotherapeutics company that is committed to delivering the best in innovation and development of next-generation T cell immunotherapy.
Casana
Chairman
2020 - Present
New York, NY, USA
Casana is an innovative health monitoring platform that helps caregivers accurately manage their patient or loved one's health status at home.
View allHide

Advisory Roles

BrightInsight
Advisor
Mar 2021 - Present
San Jose, CA, USA
BrightInsight is a leading regulated, medical-grade IoT platform for the biopharma and medtech industry.

Previous Board Positions

Vertex Pharmaceuticals
Board Member
2009 - 2012
Boston, MA, USA
Before his appointment as Chairman, President, CEO and eventually Executive Chairman of Vertex, Jeffrey Leiden served on the board of the company from 2009 to 2012.
NHLBI | National Heart, Lung, and Blood Institute
Board of Scientific Counselors
1994 - 1999
Bethesda, MD, USA
The National Heart, Lung, and Blood Institute (NHLBI) provides research, training, and education as part of its commitment to supporting the prevention and treatment of diseases affecting the heart, lungs, and blood.
View allHide

Media

A Tribute to Jeffrey Leiden: Forbes Lifetime Achievement in BioPharma Award | 2020 Forbes Healthcare Summit
Honoree
Dec 2020
Dr. Leiden is honored with the Lifetime Achievement in BioPharma Award for his exceptional contribution and lifetime achievements in biopharma during the Forbes Healthcare Summit. He talks to Steve Forbes, Chairman & Editor-in-Chief of the publication, who presents him with the award.
Vertex Pharmaceuticals enters new era of leadership with CEO Reshma Kewalramani
Featured
Apr 2020
Vertex's Chairman Jeffrey Leiden refers to the company as Vertex 3.0 as CEO Reshman Kewalramani begins to update the products portfolio for new drug development.
View allHide

Publications

Leading through the Unknowable
Author
Apr 2020
In an article for the Milken Institute, Jeffrey Leiden discusses Vertex's response to COVID-19 as a company and how the company has come together to aid the greater global community during the crisis.

Memberships

National Academy of Medicine logo National Academy of Medicine logo
National Academy of Medicine
Member
Washington, DC, USA
The National Academy of Medicine is a private, nonprofit institution that provides objective advice on issues related to science, technology, and health. It is one of three academies that make up the National Academies of Sciences, Engineering, and Medicine in the US.
American Society for Clinical Investigation
Member
Ann Arbor, MI, USA
The American Society for Clinical Investigation was established to support the scientific efforts, educational needs, and clinical aspirations of physician-scientists, who are dedicated to improving the lives and health of people across America through their work.
View allHide

Awards & Endorsements

Forbes
Lifetime Achievement in BioPharma Award
Dec 2020
New York, NY, USA
Steve Forbes, Chairman & Editor-in-Chief of Forbes, honored Dr. Leiden with the Lifetime Achievement in BioPharma Award for his exceptional contribution and lifetime achievements in biopharma.
Boston Magazine
100 Most Influential People in Boston
2020
Boston, MA, USA
In recognition of his leadership and innovative work through Vertex, Dr. Leiden was listed as one of the 100 Most Influential People in Boston by Boston Magazine in 2018 and 2020.
View allHide

Business Interests

Cardiogene
Co-Founder
1994 - Present
Marlborough, MA, USA
Cardiogene was a gene therapy company that Dr. Leiden established along with Drs Elizabeth and Gary Nabel. It has subsequently been acquired by Boston Scientific.
Vical logo Vical logo
Vical
Co-Founder
San Diego, CA, USA
Vical is a biopharmaceutical company that is dedicated to the development of products that help with the prevention and treatment of chronic or life-threatening infectious diseases.

Fellowships

Harvard Medical School
Board of Fellows
Cambridge, MA, USA
Founded in 1782, Harvard Medical School is the graduate medical school of Harvard University and is located in the Longwood Medical Area of Boston, Massachusetts. The Board of Fellows advise the Dean and administration and support the institution with its vision to alleviate human suffering caused by disease.
American Academy of Arts & Sciences
Fellow
Cambridge, MA, USA
The American Academy of Arts & Sciences is an independent, multi-disciplinary, non-partisan research center which develops and promotes knowledge through projects and publications.

Jeffrey Leiden’s Education

The University of Chicago
M.D. in Medicine
1979 - 1981
The University of Chicago
Ph.D. in Virology
1975 - 1979
View allHide